ACRX - Earnings call transcript Q1 2020

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Welcome to the AcelRx's First Quarter 2020 Conference Call. This call is being webcast live on the events page of the Investors section of AcelRx's website at acelrx.com.

This call is the property of AcelRx, and any recording, reproduction or transmission of this call without the expressed written consent of AcelRx is strictly prohibited.

As a reminder, today's call is being recorded. [Operator Instructions] You may listen to a webcast replay of this call by going to the Investors section of AcelRx's website.

to Financial call Officer. like Asadorian, to now Chief AcelRx's would turn over the Raffi I

Raffi Asadorian

XXXX a Thank website. Earlier and available our quarter in today, for the we results you joining this section announced previously us slide presentation the previewed call press Investors release. This press this accompanying afterbiib. financial releases in are first our of

with Also, Pam Vince today call With Chief Dr. of Director Chief our Medical his Services Christian Health are Dr. of who us the who Wilson Center, and Angotti, the Palmer, me on experience will Medical Tvetenstrand, Officer. today Officer; Executive our share Trauma Chairman DSUVIA at with Hospital, United the and is is Surgery [ph].

the that forward-looking will listeners of future with AcelRx. the current, operations call, Before discussion statements. to releases results involve meaning forward-looking of reports our the I'll the during statements and for Securities the press and we Please addition refer make Laws. forward-looking These risks and with associated Federal Securities statements remind we risks within Commission and Company's of regarding annual a this Exchange uncertainties periodic, begin, such filed the to in

over call now turn Vince. I'll the to

Vince Angotti

I Thank these safe today. and and joining you, challenging you sincerely well times. morning, Raffi. And your good call everyone. our during you hope families are We appreciate

by call today's Tetraphase. our planned addressing begin briefly to like I'd of acquisition

commented to further time their press to received Tetraphase La that proposal bit support at are recommend continues Jolla that acquisition disclosed We a recently AcelRx. acquisition Company. from in by shareholders they and the Pharmaceutical note are that that the earnings We the release. important aware Tetraphase a this board on Jolla La our proposal reviewing It's competing

which consider AcelRx could $XX.X upfront or respond should a in take such a would closing with specified change recommendation period notify at of that Tetraphase to to intends approximately making of million. us action. consideration price it is the the Tetraphase the in our as time board favor today's transaction, Tetraphase Now stock have before

remain agreement education AcelRx each has been co-promotion the our Tetraphase and to begun. an fully respective which and companies Further, teams fully customers both to have trained promotion on of other's commercial committed products under

that Its companies Tetraphase an Tetraphase place, AcelRx offer to remember in regardless our at significant of to ultimately would between transaction, additional time. chooses remain shareholders two the financial than board co-promotion whether updates regarding other agreement the safeguarded our accept to We'll the provide obligations. by the appropriate

then Tetraphase the real-world key with surgeon achieved ago. couple We team of COVID been you'll DSUVIA I'll hospital this, which then of agreement. Dr. DSUVIA a on you will the of results a of will Dr. and were business. was turning objectives on the C with on the commercial preview some on team The update also approval our and provide of our Now Palmer Defense. the to of Milestone one commercial significance co-promotion Department recently I'll details our provide impacts the on of at York hear from on collecting of key experience findings where Director and an preannounced treated patients. and financial Tvetenstrand, Chair Trauma which New weeks update metrics our he's on Surgery data Raffi and the Christian prominent early

So let's begin.

the within pain the DSUVIA to internal kits US DSUVIA Army is of all modernizing in or case approval, sets of achieved treatment approval approved SKOs all practice, the the projections. announce acute of is in the Milestone use that high for SKOs. means our that April outfits and validates the in DSUVIA's key The now end was for What in this military. role excited We're C at which

more great and is than had news expected. this we So

size a orders orders will of better military forecasting larger QX the team for believe We're with some but QX federal preliminary begin and DSUVIA. getting begins. the year new QX, in the on the timeframe, orders of initial the timing in Working project timeframe fiscal understanding government's currently the the when

point, the next At US orders the we stocking alone deployment will over schedules. million of based approximate that years $XX SKOs for three expect timing troop Army initial the on this

and of to Needless on gives the long by approval branches approval to the strong foundation facilities. collaboration a adoption serve areas other additional a we to say, well of result we're treatment term as proud as will agencies, which doors which signal build. open as receive is And of with us the this military of to and governments US validation and will military very our This will expect it further Department to Defense. federal the state

with Department available, the more on we we year. DSUVIA's thrilled achievement. we're step becomes Joint which Deployment will occur the with suffice say, later next will the but be inclusion this provide believe information it this to Defense Specifically, expect as to We'll Formulary,

to in goals be have pandemic, visibility hospitals health care centers facility pharmaceutical XXXX approvals greater response April, and in-person to with ambulatory surgical previously year meetings personnel. restricted once are into Accordingly COVID-XX restrictions facilities there's company in COVID-XX and formulary As and access. the re-evaluated end communicated REMS-certified lifted

To color, pace the the for our goals approvals facilities exceed give and it XXXX. COVID-XX of bit on pandemic, more to prior we REMS-certified to impacts a formulary are

and formulary following approvals number of XX was REMS-certified impact initial respectively. the of XXX COVID-XX facilities As a XXX April and of

and states available. access better believe end access, beginning While our once by to we visibility year provide approximately of initiated are new one original open will that is be for [indiscernible] virtual guidance We goals achievement have delayed in-person quarter. XXXX metrics a more meetings. also estimate up will

cross our co-promotion and the accelerates currently are agreement underway. Tetraphase teams AcelRx and promotion are As trained efforts a combined under reminder,

pain the care real of world remain acute of DSUVIA acceptance DSUVIA key is of confident the supervised for the a will formularies As the we before, settings. we medically processed, adoption from eventual using said protocols and based DSUVIA, health practitioners treatment results management become on on the

DSUVIA and time, of care on to witness real transformation Changing is believe this not to used in beginning how settings. a professionals will care takes of being Dr. space. management standard acute but pain are elaborate practitioners the see health we world more Palmer

Pamela Palmer

Thank you, Vince.

hear feedback about are health the world gathering and and to unique to settings. real supporting important continues clinicians using pharmacokinetics advantages benefits of most are DSUVIA and practitioners care patients, analyzing the to continue and aspect report data now how care Physicians health be its DSUVIA We of they profile. DSUVIA its

of conducted and animal onset in a a of safety index cognitive concentrations measure provides profile analgesic and and is to rapid which The high This dampened impairment, duration peak therapeutic lack its index. of models. extended attribute clinicians therapeutic action, of its a drug plasma

based hospitals DSUVIA been important data treated two by Practically the findings on gathered speaking have patients. some observed in

the decrease First, dramatic post-anesthesia is unit in And the second, to a be care required patient a in substantial in or PACU. decrease IV opioid PACU. the requirements time in

months. We be full in expect coming the the in published to studies

the and This DSUVIA directors in setting. critical are truly stakeholders. other showcasing informative these data physicians, is findings hospital can of to they administrators, perioperative published, Once pharmacy used educate be

published who On one experience will be perspective discussed useful general anesthesiologist would We director of and be plastic surgeon to substantial DSUVIA of and the community. previous the have calls, a author the surgeon and a investment be a studies, their in sharing experience. of lead soon has thought to with these DSUVIA pharmacy

surgical of I Tvetenstrand, care director and of as is colorectal a chairman who care. specializes and Christian to in trauma a surgery New in general am bariatric, surgeon where very He Services pleased trauma. Medical York United Wilson Dr. as the today to provides you Center, Health at well critical surgery, introduce patient he Hospital

his Dr. Tvetenstrand began surgical who February administering his of notably has to patients, DSUVIA patient expanded his population in trauma to are use elderly. recently more most DSUVIA and those

I some following trauma information is care to safety Before observations surgical his cover DSUVIA. information discusses in Dr. his for will using intended Tvetenstrand professionals not or DSUVIA The with patients. investors, about health and patients,

patients concomitant that Schedule addiction, or medically pain opioid may inadequate. DSUVIA management respiratory [ph] a certified be only treatments XAX setting analgesic care in adult and include, central interaction, which alternative for require is benzodiazepines from with to use a enough dispensed of an misuse, the Risks depressants. to cytochrome substance other health system life-threatening acute for and PXXX supervised are nervous depression, II severe risks controlled abuse,

reactions with the caution in with dizziness data of the hypertension. The use in due and are on organs be Insufficient adverse excretion patients metabolism severe are vomiting, liver in patients of or importance most the used nausea, should these headache, reported such kidney DSUVIA available commonly sufentanil. to DSUVIA impairment. of and

and train evaluation on part administration must procedures of acute ensures and DSUVIA be mitigation opioid the strategies that of administer facilities via physician AcelRx policies relevant Facilities able that the DSUVIA. available are DSUVIA implement is program. risk to REMS DSUVIA and or overdose, REMS only program. DSUVIA DSUVIA staff the manage to of use ensure proper to DSUVIA appropriate education

for For DSUVIA.com. DSUVIA can safety found warning information the at be black box

Now, to Tvetenstrand hand with DSUVIA share his I acute in would pain. their like and to Dr. call to the patients hospitals over managing experience

Christian Tvetenstrand

Dr. you, Palmer. and DSUVIA speak my experience for our at hospital. D. not you Dr. to being excited I'm note, all. time Christian Of with Hello, Thank with compensated Tvetenstrandand I'm about our tell to you I'm today.

AcelRx. compensated However meeting board previously attending been an have I with advisory for

surgical with was and in higher of obese are I drug. for effects patients, at DSUVIA multiple trialling the of patients all side and after operate initially comorbidities, post-operatively. my pharmacokinetics in often patients patients of interested elderly learning on complications I whom the risk

[ph] and in enhancer patient's pain concentration especially opioid patients, major interested While and To is we include its surgery the analgesia steady I and duration optimize utilize plasma of for regimens, extended we opioids. relief after a low regimen go to going these action. all at-risk multimodal for outcomes, was DSUVIA this analgesia

and of to the IV that lows PACU injection and When the following we we of The re-dose plasma breakthrough and finding short pain. for have can is confused the fall in ideal over are rapid patients the especially become they each the levels rapidly sedated IV fentanyl, have quickly opioids, drug concentrations fentanyl continually we as then patient use and duration do we off highs action. these not then

quickly comorbidities build level to of active These which in clinical the a with validated DSUVIA metabolites decision effects. metabolites impairment Six-item tool elderly in was the up no the risk system increase has using that initial to Dilaudid. with AcelRx the Screener, showed nervous cognitive no important. can and significantly active fact data these or can morphine the DSUVIA metabolite higher utilize patients in cause common research as impairment such patients levels that Renal opioids my central quite important having surgery very Also blood after trial

dose operating to As room. XXX bringing DZUVEO DZUVEO back over them to I mentioned From [ph] since preoperatively prior have surgical patients single minutes a the approximately February XX I my dosed patients with

home. to This DZUVEO so surgeries. discharge initially we clear critically have important these facilitate in in We to patients is focused use maintain outpatient a can our of headedness rapid

confusion nausea a severe with with as side our many significantly discharge and flow. time utilized medications delirium notably in Most delay Patients post-operative or perioperative effects seriously vomiting post-op can to patient such can including the can setting opioids. impact and have surgical elderly

The all were a believe would that of hesitant an single an hour the patients take opioid first not surgery. I patient dosed that the the hospital, trialled for I anesthesiologists it's in to need overstate. to or The so as their the DSUVIA some, in my undergoing been complexity. These quite well be nurses To it abdominal say results have shocking in dose on PACU, DSUVIA typically as four cases day analgesia. depending would

during surgery. required of multiple In Minim are alert a Normally and opioids to PACU dose case. up are immediately doses during required after few and operative delivering a been the would case. patients the no patients waking even oriented have DSUVIA they lengthy Only second the comfortable. IV fentanyl after have of other

period analgesic a would time extended last from the of of as the review So an expect pharmacokinetic. you

of decreased overall on stay. has and instead the further the opioids in more moving of patient PACU in having use extends of patients, freed them more care to opioids Our administer the which their has nurses to these focus towards IV up discharge and find clinical we

the for ready time our controls. DSUVIA collecting a to our there to historical been discharge for all and in is on the reduction time have dramatic patients patients to needed be compared discharge data We

not us. and we vomiting. no and It seen have changer minimal We for respiratory have seen has depression really very been nausea game a

the interested treat We to patient learning be surgeons effects, side of process dosing analyzing are way data new other in pain quite for a in as to I severe while potentially in and overall moderate that fully setting reducing opioid the decreasing currently believe who’d acute the discharge in the time. - about publication, minimizing perioperative

use second interest My patients. was area the elderly DSUVIA for of for the in

after rapidly them of typically observed elderly decline after can have morbidity are the I multiple see emergency For and years admitted times traumatic we cases department sidewalk are event. are the in acute hip initially many quite patients a with facility. winter the the These to myriad and to hip back femur, nursing types with arm on other these home some injuries. and slips patients a discharged skilled fractures, to In relegated of fractures never

Treatment build of is mentioned of when function doses is up repeated opioids. finding severe especially can pain And common a can have renal commonly diminished, often used before the elderly. require most that active time, which metabolites opioids over in as

stays. This which spiral. we patients DSUVIA mental the felt treatment of results delirium, that can often extended could in leading if in these I could avoid clouding, rehabilitation confusion downward mobility this early impair we utilize to on

dosed and newspaper for on patients. he I check puzzle. I went old the opener night in hospital was two with gentleman who My DSUVIA. department One broken day. using year his XX the is see doing eye the hip him, an was awake, That something had After reading a DSUVIA comfortable, you had emergency every the to remember distinctly back first crossword first he and a of been me. was was not

IV woman, concerned. dosing patient treatment. second broken initially and common patient her after was had and with hip and quite her a was The elderly disoriented and she confused the she quite which family too The is fallen was dosed an Dilaudid

family was her with off quite quite the and then elderly she relieved. now her few examples of DSUVIA time was left observed, just and and lo and I These again two hours I dosed was are where trauma lucid and patients. and what I've Dilaudid a time for controlled behold pain the

and DSUVIA, safety feel DSUVIA only that Overall, I not surgical severe simplified the to treatment and of efficacy my patients. acute the with am trauma I in pain moderate impressed the of but acute has

renal doesn't and is matter anesthesiologists not same has of difference, microgram. that dose [indiscernible] XX patient the always tongue also or IV whether impairment have young not, frail Our they're nurses men or recognized whether the an old the under or being

very can expanding and in where benefit publish pays at it to in to redose our it the operate. I'm after our patients, population to as have and our care important I share forward have inpatient, to we patient hope the given been more Wilson of Medical systems. your benefits department. well surgical kind hour, the the and Thank added product for While I our Center, DSUVIA to we DSUVIA use other all is data formulary other at hospitals observed emergency you providers itself. use am necessary an knowledge looking the I our for has rarely hospital as excited attention. than expanding experience to of DSUVIA health

Vince Angotti

your available of some questions. I additional you, hope be the during another sharing of today's Thank experience call will for portion Dr. and any to provided yet Tvetenstrand remarks world Q&A those perspective real application your answer Dr. on of Tvetenstrand DSUVIA.

to I'd you take the like through to to hand Raffi the financials. call over

Raffi Asadorian

Thanks, Vince.

first of from cash short with which We with term DSUVIA. We as ended launched year investments, cash million remain the in we $XX.X million $XX.X and quarter continue prudent end a represents to change XXXX. our

net the comp. by SG&A was our million stock-based outflow stock of Our and combined million cash for $XX.X quarter or R&D or mainly cash including comp operating expenses, $XX.X expenses excluding driven

of of million of non-recurring driven Tetraphase the of costs included launch the expenses. in million of $XX.X related compensation. $X.X was by operating operating This $XX.X quarter increase which approximately commercial in quarter DSUVIA. XXXX The first stock-based The cash expenses mainly or including related compared to the million expenses transaction to

and the on that most the in cash positive investing overall our continue have on will prudent in launch the impact spend. to focus remain areas We

the quarter Revenues $X.X million for the to $X.X first million were compared quarter XXXX in first XXXX.

in We continued which March healthcare noted. on beginning facilitating Vince DSUVIA, access our to institutions focus as was slowed

we well-placed PACU. backlog volumes, capture have important as believe surgeries the of efficiency even sales by increased the also DSUVIA postponement in with to surgeries, surgeries been becomes the is increased elective elective the of restart more Once DSUVIA impacted across country.

in with with initial Defense, the project years. year better expectations Finally, discussions size the understand the and sales order timing with years coming And and the team three as million deployment remain troop approximate Army $XX regards US our our the we approximately for over orders schedules. close the stocking Vince SKOs mentioned, of - our of Department alone to based to expectations for timing for will next on

federal And of branches of then and they on other DSUVIA. military top see could of as military's and that, approval other and agencies, state use additional see also from the orders a the Army, we the

manufacturer operational volume has packaging restrictions been and Our travel at installed due from is this to expected to delayed contract our line be later year somewhat COVID. high that

We final our will cost to line. of the eased be expect acceptance significantly once for commercial year, running of restrictions production production this paving these which way later is equipment reduce the this on

To are well meet as from customers, the DoD, the timing acceptance manufacturer. tests of evaluating equipment the to accelerate volume demands final alternatives as from commercial we

rest cash for from including stock-based $X.X the are impact of to excludes compensation Our operating XXXX a Tetraphase the year, acquisition excluding the $XX which quarterly stock-based or million million, expenses to $X compensation. million million range $XX to expected from

consummation provide guidance to acquisition. of expect We the following updated

discussions our have to partner in here in more and in to Finally, months. out DZUVEO Europe report we potential coming the hope for licensing remain with

potential customer and specialties, U.S. around to We US. such collaboration and distributing the DSUVIA are in surgery also oral with as in plastic discussions partners marketing non-core

to to with licensing focus add active assets and in are value In are to addition, discussions that in significant we've complementary business. portfolio our development the potential continued our on business existing

opioid the from more FDA details hope opportunities are future. delayed evaluating approval Zalviso regarding further resubmission these our a NDA timing near the the on we of We have still new in potential framework. guidance pending product Finally, to we which

to back me the turn over Vince. call With that, let

Vince Angotti

Raffi. Thanks,

summarize, we DSUVIA’s So medically market, settings. that believe and to with to continue supervised term team We the point ability were metrics. for success pain standard-of-care acute long in before as at sales full quarters three in well our the to DSUVIA access launch its management in of benefits exceeding hit, the only as COVID--XX strongly change were we our

that continue we trend once restrictions lifted. So are expect to

in As the positive. in care forward setting. the We DSUVIA about you've data DSUVIA showcasing publications practitioners health the perioperative dosing feedback early look to heard, the the is

management a support to we hospitals DSUVIA and Finally, centers. the we're Milestone DoD CE to catalyst business revenue our for surgery foundation path receive bought This excited as pain a paving into stream approval to the you acute modernizing military. for launch continue within and as ambulatory

Before I on for like beyond Tetraphase going note, the La Q&A, be to just release. what have said we commenting [ph] Jolla I'd we that our bid in won't further

So we and to updates. first business to questions our your limit you other ask quarter results

for to might you I'd questions And the like open have. line Operator? any

Operator

[Operator Instructions] First ahead. Fitzgerald. of from question Please Brandon comes Folkes Cantor go

Brandon Folkes

congratulations and for all useful? seeing Thanks quarter. type seeing my perhaps of questions surgeries it useful hospital Hi. on perhaps elaborate in you're where progress DSUVIA, what just even the the taking being Could the during are you you

on see you in settings where for suited you. opportunities or ASC are the those do [ph] Thank within type the DSUVIA? hospital do And the of surgeries then think of that, flipside what you And best

Pamela Palmer

responds and on pain, wonderful pain, But thing whether can Well, Sure. well you opioid types about a the medication. pain, nerve pain of it's all soft Dr. bony tissue really well, add I'll all orthopedic that even I to treat tell they Tvetenstrand, comments opioids is injury his afterwards. have

your like talk really isn't would experience? surgery with you But of utilize Tvetenstrand, DR. limit can that a there the DSUVIA. about to you further to So type

Christian Tvetenstrand

that lot laparoscopic procedures are started A we invasive absolutely. looking yeah day do the operation, of so laparoscopic of started, these same cholecystectomy’s, patients are I surgeon, and principally States. these our an discussed. we laparoscopic hernias, Oh, minimally this where in procedures advanced United a common results the is those And most at am surgery. lot I we

the home I without was a And the would thought significant that they able surgery she for emphysema experience it ICU respiratory comorbidities, you was did I patients, patients woke have cases of hospital these to in of comfortably the the care I will. with so types But and out with was and patient cleanly, patients with depression. stunned I other ICU to after had that I if much quicker that went areas any that absolutely to up severe stunned, ventilatory have might I able use go than the anticipated with keep to [ph] comfortable on otherwise. COPD

and So want [ph] there's these same possible. start cases of as there many are when well Palmer there's out of their are Dr. to day - where the at a lot are to said, using areas recipes our cases quickly a this patients hospital as they in clear - drug bit the as procedures as and chomping PACU

where be has emergency whole the So then to plethora needs - and department of of course pain treated. a areas

Vince Angotti

which mimicked question? Dr. which often Dr. we're the or doing answered Tvetenstrand. typically helped. hour based surgeries your hope looking same general and and I the hours surgeries, same they Brandon, is flow And in that matters [ph] off efficiency to keep that I they're to ASCs an hope some Brandon, In discharge is the Tvetenstrand day it United seeing obviously for throughout relative the moving. to they're perioperative patient additional day two just are the the to add outpatient Thanks, color of adoption States early hospitals

Brandon Folkes

congratulations did, the again. much very Thank progress on and well. very all It you

Vince Angotti

Thanks, Thanks. Tvetenstrand.

Operator

next The of comes Ladenburg Thalmann. ahead. Please Higgins from question go Michael

Unidentified Analyst

is you questions. Edward Michael. appreciate taking This Hi. guys Marks the on for I

advancements in about, you movements were you of wondering looking that might those order branches? from branches further military the when are to DSUVIA regards and see in what those just some So I'm approve other we talking to

ordering reciprocal like equipment. for we And U.S. has medical kind then something NATO relatedly, through that military the relationship a of believe

might countries to other begin like the wondered maybe or of Just NATO organizations DSUVIA? some when use

Vince Angotti

[ph] the Evan Thanks, for Yeah. question.

bit little color of to a add just that. I'll So

C project positive of the Milestone the that out the from signals completion the So and its really implementation. transition

joint transition this DSUVIA deployment now be added formulary. allows I your to think to the question, for relative to

months. few over next So the we expect that

as from So branches DSUVIA other to the will orders be include Army able medical troops their add kits SKOs in well. will government of into the deploying as only for their DSUVIA not initial U.S.

for We to we've accounted provided haven't that you. and estimates the

Milestones the addition Patrol state might validation two Those federal cetera. - believe et we to of FBI, U.S. JDF as approval will signals Border the and the C Marshals, agencies, events serve examples the this U.S. other consider

will the deployment So in the to we we post other months. formulary which the happen to branches think expect three happen two next

NATO them. and and been C focused through that, opportunity ordering, forward. to But the opportunity catch. we supporting US do but approval haven't believe And Relative reciprocal we've moving we To an those we moving and certainly really quantify the forward Milestone on getting estimates that been well. that haven't - good will that be an generated as is yet,

Unidentified Analyst

And Good Excellent. the talk $XX to particularly with estimates, those hear. you about when million. then

million around the the this half Does ‘XX. the next $XX in rest like year of the occurring accurate? $X some three maybe wondering million year in that a of Just ramp maybe the ‘XX second and this and if years, $X sound through something of million over assumptions balance to in

Raffi Asadorian

Evan this is Rafi.

confidential So we the to on - need obviously military those on based schedules. it's get to estimates on the joint deployment the from because information wait

million are not from is initial in stocking is that $XX those - So or orders, mind that also anything. keep use just

We per information to privy know the - loaded. get So actual top army how deployment it that be the pack initial that would actual, to is front of And we outs, to don't be you again use for schedules that's that on have is it's know, to just replenish. split year, wait the just SKOs. going that to be, is we're we going that much don't because But you yet to to. need not that evenly have on

Vince Angotti

just additional is to conflict that little Raffi if as of repeat I on think not on to use the on ordering the et color, a medics area that, amount a cetera. in depend depend considered I use is mentioned, there think meantime, in add will the

in facilitating hospital military know at and schoolhouse our should surgeons in by and short be happening we'll training counts near there term future team for as Army done You will that the and planned personnel the the the field battalion for is very accelerates brigade be that the federal training medics well.

the So lot product the there's throughout activity Army. of a around

Raffi Asadorian

add which and case to not is SKO's all very just - - it their high into right. and our kids our their This of outfits. this that that sets putting Yeah they're that was was was pleasing all going this Army in base to so into see was was case

Unidentified Analyst

And all good me. to guys. hear. that's that's Thank Excellent, for you,

Vince Angotti

Thank you.

Operator

The next question comes H.C. ahead. Arce from Please go of Wainwright. Ed

Thomas Yip

afternoon, Yip is Thomas everyone. for questions Ed. Good This couple of asking

congratulations news of DSUVIA First, great with also this more real hear far your on DSUVIA year so and to life today. progress

that? JDF DSUVIA’s order. expect at outlines about the question that's First schedule And potential impact purchase expect that in or stocking clear contract? how military Where stuck way does on to very Should we a needed. formal a this year, any potential

Vince Angotti

overall they deployment pack where relates kits also as dependent so the question final depend initial it orders. three those will for details it troops those to of just part was not as have second the the schedules just and it's the the preorder we Thomas? the schedule, that on the schedules on of deployed, as of Yeah, and that years to communicated over gotten deployment medic significant they've the of next fairly What kind that are

Thomas Yip

That's how for does I JDF patient? that change order guess

Vince Angotti

Yeah.

So C.. the the of process following JDF the part is Milestone

three expect next that months. two we the to in So to happen

- pack then SKOs moving to medics, for just but that them of with outs the the volume for Coast be Air that significant in balance it their Force three we'll forward. consider up Guard, allows they're Navy is branches So add or believed the whether additional opens military branches, it called not will which

Raffi Asadorian

stocking that orders there's been There's again use now actual it. parts it's of - use those that And DSUVIA, the gets ongoing are the all Then of it approved. there's to two DSUVIA off. this into

Thomas Yip

formulary regarding both the channel second on and switching base to chance certification Thank clarifying. COVID-XX Are to question review, fronts? on has of now. ongoing Okay. that you there as you any mentioned due my And virtual to for REMS been hold for

Vince Angotti

as it available eased to face relates so key a not geographies happening to solid customers and COVID making But pending virtual very we're our see with been face. we some regulations reception. respective Yeah already to to them with early there's the their absolutely, access But for and their calls. starting was those or availability shifted of what for

to an last executed scheduled boards. in we Just as the advisory month originally They engagement all face full attendance during virtual face with had were three manner. a and example

cost was virtual high. meetings. it but from face to swift I efficient in-person engagement extremely I you face tell a was So shift And in to can the was

our virtual beyond beginning webinar perspective now of moving our with speaker customers. addition from use representatives sales team in in for their to programs cost sales that also virtual a the are be national and we're these centers other week, can starting tactics in the nature communications just exploring this We're forward instance

So active are the in space. virtual we

to virtual looking and We as converted meetings of have some those forward. norm to the moving already results really create with part that planned, strong of the space very

Thomas Yip

and early that good. can And - that you gear merger DSUVIA to efforts sounds between but the [ph] a for promo Yes, cold effort in then ally DZUVEO switching the for some necessarily perhaps not for co-promo?

Vince Angotti

timing. give highlight, early the to I'll background Yeah it you on is a just

where so were customer with about week of worth weeks merger right they that the ago, and calls. that following we DSUVIA our breaks team, announced training course about right the the weeks for into teams the our we went we had it took restructured DZUVEO during of now agreement, virtual making was went four training the five week when that complementary following in I So their time think we [ph] into for that

and co-promoting the from Texas has teams So begun in access you're response week about more respective less dependent highly profiles on now, receptivity really access. Georgia of from products. the excitement you geography teams both might access last far penetration of just whether the customers for have right the both products of it's and each thus field Again, parts or have and might has the you been other's respective Florida parts northeast

level combined face related high on done variable So the training but from strong to high, the been it's that the a at was face the team. very engagement and energy has to the

Thomas Yip

and forward questions more looking Thank to hear. progress you see year. to our Good this taking for

Vince Angotti

Thank you, Thomas.

Operator

This any to answer turn concludes over Angotti to conference the session. like I would Vince our remarks. and back closing for question

Vince Angotti

the news for army, not of this for and support you was the with belief that month, see or being our for but up other military our moving foundation for government's forward That that pursuant of product of our We open important that it a based will and base our validation and in the believe joining only by company of our and civilian at forward. as only us AcelRx. our well us and It base creating past that of the over ordering accounts military initial today Thank personnel. very a really backing continued the to the for for of further course the people. provides off even your moving non-military expand business use the branches milestone

you hope the your and future all So with support thank We today AcelRx. at us you in and Thanks. look to more you safe. we joining for forward sharing developments remain continued

Operator

now presentation has Thank The concluded. attending you for may you disconnect.+ now today's conference

Talphera (TLPH) 11 May 202020 Q1 Earnings call transcript